The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -56.98%.However, over the last six months, we can see a stronger performance of -16.18%. Over the last 30 days, the price of BDTX has leaped by -13.64%. And in the last five days, it has fallen by -14.29%.
At present, Black Diamond Therapeutics Inc (BDTX) has a stock price of $2.28. In the previous session, the stock saw a rise, peaking at $12.0 after an opening price of $2.28. The day’s lowest price was $9.0, and it closed at $2.69.
Black Diamond Therapeutics Inc’s market performance has been stable in recent times.
52-week price history of BDTX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Black Diamond Therapeutics Inc’s current trading price is -66.22% away from its 52-week high, while its distance from the 52-week low is 90.79%. The stock’s price range during this period has varied between$1.20 and $6.75. The Black Diamond Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.87 million for the day, a figure considerably higher than their average daily volume of 1.17 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Black Diamond Therapeutics Inc (BDTX) has experienced a quarterly rise of 47.10% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 129.65M and boasts a workforce of 24 employees.
Black Diamond Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 3 analysts are rating Black Diamond Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.14, with a change in price of +0.56. Similarly, Black Diamond Therapeutics Inc recorded 2,628,363 in trading volume during the last 100 days, posting a change of +32.56%.
BDTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BDTX stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.13.
BDTX Stock Stochastic Average
As of today, Black Diamond Therapeutics Inc’s raw stochastic average for the last 50 days stands at 24.18%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 5.48%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 18.65% and 26.61%, respectively.
